Germain Margall Ducos

Germain Margall Ducos has a diverse work experience in the field of scientific research and project management. Germain began working at Pierre Fabre in 2009 as a Chargé de projet before moving to CNRS later that year as a Chef de projet en immunologie/oncologie. At CNRS, they led a project aiming to determine the effectiveness of monoclonal antibodies as therapeutic agents in glioma treatment. After their time at CNRS, Germain worked at BliNK Biomedical from 2013 to 2018 as a Chef de projet/manager. Currently, they hold the position of Principal Scientist at HiFiBiO Therapeutics, where they have been working since 2018.

Germain Margall Ducos completed a Doctorate in Molecular and Cellular Biology at Pierre and Marie Curie University from 1999 to 2004.